Analysis of the factors associated with non-adherence to therapy with home-based remote monitoring noninvasive positive pressure ventilation in children with obstructive sleep apnea-hypopnea syndrome and risk factors.
- Author:
Da-bo LIU
1
;
Jing ZHOU
;
Zhen-yun HUANG
;
Jian-wen ZHONG
Author Information
- Publication Type:Journal Article
- MeSH: Apnea; Child; Humans; Patient Compliance; Positive-Pressure Respiration; methods; Remote Sensing Technology; Risk Factors; Sleep Apnea, Obstructive; therapy
- From: Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2013;48(8):677-679
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo discuss the factors associated with non-adherence to therapy with home-based remote monitoring noninvasive positive pressure ventilation (NIPPV) in children with obstructive sleep apnea-hypopnea syndrome (OSAHS) and risk factors.
METHODSTwenty-one children with OSAHS and risk factors from March 2001 to December 2012 were enrolled in this study. They all received home-based remote monitoring NIPPV therapy. After admission, all children underwent NIPPV titration, then the parents were trained to operate the ventilator, after that, the children were discharged. Remote monitoring started to monitor NIPPV parameters and the adherence to NIPPV.
RESULTSUnder remote monitoring, ten children (50.0%) were adherence to NIPPV therapy. Seven children (31.8%) gave up NIPPV therapy within one week and four children (19.0%) gave up one month after NIPPV therapy started. The reason for non-adherence was as follows: 3 cases (27.3%) had some economic problems, 3 cases (27.3%) considered NIPPV therapy as a inconvenient therapy and lost patience; 2 cases(18.2%) resisted the therapy and 3 cases (27.3%) could not tolerate the therapy.
CONCLUSIONSUnder remote monitoring, non-adherence to home-based remote monitoring NIPPV therapy is still high in children during the early treatment, mainly due to economic problems, intolerance to the therapy and lack of the recognition of the importance of the therapy.